Personalized medicine and treatment approaches in non-small-cell lung carcinoma

Medicine and Dentistry

• Therapeutic Procedure 100%
• Non Small Cell Lung Cancer 100%
• Personalized Medicine 100%
• Patient 83%
• Lung Cancer 66%
• Epidermal Growth Factor Receptor 50%
• Epidermal Growth Factor Receptor Kinase Inhibitor 33%
• Combination Therapy 16%
• Histology 16%
• Excision Repair Cross-Complementing 16%
• Platinum 16%
• Anaplastic Lymphoma Kinase 16%
• Receptor Expression 16%
• Fusion Gene 16%
• Receptor Gene 16%
• Spine 16%
• Crizotinib 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Lung Cancer 100%
• Non Small Cell Lung Cancer 100%
• Epidermal Growth Factor Receptor 75%
• Epidermal Growth Factor Receptor Kinase Inhibitor 50%
• Platinum 25%
• Chemotherapy 25%
• Crizotinib 25%
• Anaplastic Lymphoma Kinase 25%
• Cytotoxic Chemotherapy 25%
• Microtubule Associated Protein 25%